vs
Side-by-side financial comparison of Agilent Technologies (A) and Albemarle Corporation (ALB). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.4B, roughly 1.3× Albemarle Corporation). Agilent Technologies runs the higher net margin — 17.0% vs -29.0%, a 46.0% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (15.9% vs 7.0%). Albemarle Corporation produced more free cash flow last quarter ($233.1M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 2.4%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
A vs ALB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.4B |
| Net Profit | $305.0M | $-414.2M |
| Gross Margin | 52.6% | 13.9% |
| Operating Margin | 19.6% | -15.2% |
| Net Margin | 17.0% | -29.0% |
| Revenue YoY | 7.0% | 15.9% |
| Net Profit YoY | -4.1% | -650.1% |
| EPS (diluted) | $1.07 | $-3.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.4B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-414.2M | ||
| Q3 25 | $336.0M | $-160.7M | ||
| Q2 25 | $215.0M | $22.9M | ||
| Q1 25 | $318.0M | $41.3M | ||
| Q4 24 | $351.0M | $75.3M | ||
| Q3 24 | $282.0M | $-1.1B | ||
| Q2 24 | $308.0M | $-188.2M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 13.9% | ||
| Q3 25 | 51.1% | 9.0% | ||
| Q2 25 | 51.9% | 14.8% | ||
| Q1 25 | 53.5% | 14.5% | ||
| Q4 24 | 53.9% | 11.2% | ||
| Q3 24 | 54.2% | -7.7% | ||
| Q2 24 | 54.4% | -0.7% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | -15.2% | ||
| Q3 25 | 20.7% | -16.6% | ||
| Q2 25 | 18.0% | 3.6% | ||
| Q1 25 | 22.4% | 1.8% | ||
| Q4 24 | 24.0% | 0.4% | ||
| Q3 24 | 21.1% | -81.9% | ||
| Q2 24 | 23.1% | -34.4% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -29.0% | ||
| Q3 25 | 19.3% | -12.3% | ||
| Q2 25 | 12.9% | 1.7% | ||
| Q1 25 | 18.9% | 3.8% | ||
| Q4 24 | 20.6% | 6.1% | ||
| Q3 24 | 17.9% | -78.9% | ||
| Q2 24 | 19.6% | -13.2% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-3.88 | ||
| Q3 25 | $1.18 | $-1.72 | ||
| Q2 25 | $0.75 | $-0.16 | ||
| Q1 25 | $1.11 | $0.00 | ||
| Q4 24 | $1.23 | $0.29 | ||
| Q3 24 | $0.97 | $-9.45 | ||
| Q2 24 | $1.05 | $-1.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | $3.0B | $3.2B |
| Stockholders' EquityBook value | $6.9B | $9.5B |
| Total Assets | $12.8B | $16.4B |
| Debt / EquityLower = less leverage | 0.44× | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | $1.9B | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.8B | $1.7B | ||
| Q2 24 | $1.7B | $1.8B |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $3.2B | ||
| Q3 25 | $3.4B | $3.6B | ||
| Q2 25 | $3.3B | $3.6B | ||
| Q1 25 | $3.3B | $3.5B | ||
| Q4 24 | $3.3B | $3.5B | ||
| Q3 24 | $2.1B | $3.6B | ||
| Q2 24 | $2.1B | $3.5B |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $9.5B | ||
| Q3 25 | $6.4B | $10.0B | ||
| Q2 25 | $6.1B | $10.2B | ||
| Q1 25 | $6.0B | $10.0B | ||
| Q4 24 | $5.9B | $10.0B | ||
| Q3 24 | $5.9B | $10.2B | ||
| Q2 24 | $6.2B | $11.2B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $16.4B | ||
| Q3 25 | $12.2B | $17.1B | ||
| Q2 25 | $12.2B | $17.3B | ||
| Q1 25 | $11.9B | $17.0B | ||
| Q4 24 | $11.8B | $16.6B | ||
| Q3 24 | $11.0B | $17.5B | ||
| Q2 24 | $10.9B | $18.4B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.33× | ||
| Q3 25 | 0.53× | 0.36× | ||
| Q2 25 | 0.55× | 0.35× | ||
| Q1 25 | 0.56× | 0.35× | ||
| Q4 24 | 0.57× | 0.35× | ||
| Q3 24 | 0.36× | 0.35× | ||
| Q2 24 | 0.34× | 0.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $388.5M |
| Free Cash FlowOCF − Capex | $175.0M | $233.1M |
| FCF MarginFCF / Revenue | 9.7% | 16.3% |
| Capex IntensityCapex / Revenue | 5.2% | 10.9% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $692.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $388.5M | ||
| Q3 25 | $362.0M | $355.6M | ||
| Q2 25 | $221.0M | $-7.2M | ||
| Q1 25 | $431.0M | $545.4M | ||
| Q4 24 | $481.0M | $674.0K | ||
| Q3 24 | $452.0M | $240.5M | ||
| Q2 24 | $333.0M | $362.9M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $233.1M | ||
| Q3 25 | $259.0M | $223.4M | ||
| Q2 25 | $107.0M | $-126.8M | ||
| Q1 25 | $334.0M | $362.8M | ||
| Q4 24 | $388.0M | $-355.1M | ||
| Q3 24 | $360.0M | $-62.6M | ||
| Q2 24 | $230.0M | $-84.7M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 16.3% | ||
| Q3 25 | 14.9% | 17.1% | ||
| Q2 25 | 6.4% | -9.5% | ||
| Q1 25 | 19.9% | 33.7% | ||
| Q4 24 | 22.8% | -28.8% | ||
| Q3 24 | 22.8% | -4.6% | ||
| Q2 24 | 14.6% | -5.9% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 10.9% | ||
| Q3 25 | 5.9% | 10.1% | ||
| Q2 25 | 6.8% | 9.0% | ||
| Q1 25 | 5.8% | 17.0% | ||
| Q4 24 | 5.5% | 28.9% | ||
| Q3 24 | 5.8% | 22.4% | ||
| Q2 24 | 6.5% | 31.3% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | -0.31× | ||
| Q1 25 | 1.36× | 13.19× | ||
| Q4 24 | 1.37× | 0.01× | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
